219 related articles for article (PubMed ID: 12159894)
1. Vermont to require drug makers to disclose payment to doctors.
Petersen M
N Y Times Web; 2002 Jun; ():C1, C12. PubMed ID: 12159894
[No Abstract] [Full Text] [Related]
2. Drug makers battle a U.S. plan to curb rewards for doctors.
Pear R
N Y Times Web; 2002 Dec; ():A1, A28. PubMed ID: 12561833
[No Abstract] [Full Text] [Related]
3. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
Morin K; Morse LJ
Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
[No Abstract] [Full Text] [Related]
4. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine.
Krimsky S
Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492
[No Abstract] [Full Text] [Related]
5. The Sunshine Act--effects on physicians.
Agrawal S; Brennan N; Budetti P
N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
[No Abstract] [Full Text] [Related]
6. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
Mehta RS
Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
[No Abstract] [Full Text] [Related]
7. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
8. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
9. The Sunshine Act: it's for real now.
Katayama AC
WMJ; 2013 Apr; 112(2):96-7. PubMed ID: 23758019
[No Abstract] [Full Text] [Related]
10. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
11. Charities tied to doctors get drug industry gifts.
Abelson R
N Y Times Web; 2006 Jun; ():A1, C4. PubMed ID: 16838451
[No Abstract] [Full Text] [Related]
12. Banning pens and pads misses the main point.
Terry SF; Burke W
Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
[No Abstract] [Full Text] [Related]
13. Physician payment sunshine act.
Merino JG
BMJ; 2013 Aug; 347():f4828. PubMed ID: 23908473
[No Abstract] [Full Text] [Related]
14. Drug makers pay for lunch as they pitch.
Saul S
N Y Times Web; 2006 Jul; ():A1, C7. PubMed ID: 16909492
[No Abstract] [Full Text] [Related]
15. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
Studdert DM; Mello MM; Brennan TA
N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
[No Abstract] [Full Text] [Related]
16. Are we providers or physicians?
Baxter JD
Arch Intern Med; 2009 Oct; 169(18):1725. PubMed ID: 19822834
[No Abstract] [Full Text] [Related]
17. A higher bar--Vermont's new law on marketing prescribed products.
Steinbrook R
N Engl J Med; 2009 Jul; 361(1):8-9. PubMed ID: 19516028
[No Abstract] [Full Text] [Related]
18. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
Rosenthal MB; Mello MM
N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
[No Abstract] [Full Text] [Related]
19. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
20. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
Brett AS
Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
